TipRanks
Quantum Healthcare Ltd. (SG:V8Y)
SGX:V8Y
Singapore Market
V8Y
Quantum Healthcare Ltd.
RESEARCH TOOLSreports
Want to see SG:V8Y full AI Analyst Report?

Quantum Healthcare Ltd. (V8Y) Ratios

1 Followers

Quantum Healthcare Ltd. Ratios

SG:V8Y's free cash flow for Q2 2026 was $0.45. For the 2026 fiscal year, SG:V8Y's free cash flow was decreased by $ and operating cash flow was $-0.04. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 0.49 0.54 0.28 0.34 0.86
Quick Ratio
 0.48 0.54 0.28 0.34 0.86
Cash Ratio
 0.16 0.27 0.03 0.07 0.65
Solvency Ratio
 -0.09 -0.08 -0.03 -0.14 -0.52
Operating Cash Flow Ratio
 0.10 0.21 0.13 -0.06 -0.17
Short-Term Operating Cash Flow Coverage
 0.50 2.08 0.56 -0.35 -0.99
Net Current Asset Value
$ -6.94MS$ -6.73MS$ -12.30MS$ -12.34MS$ -8.57M
Leverage Ratios
Debt-to-Assets Ratio
 0.37 0.39 0.61 0.50 0.52
Debt-to-Equity Ratio
 -2.11 -2.74 -2.11 -1.68 -5.02
Debt-to-Capital Ratio
 1.90 1.57 1.90 2.46 1.25
Long-Term Debt-to-Capital Ratio
 -0.32 -1.30 -0.97 -2.49 1.55
Financial Leverage Ratio
 -5.68 -7.08 -3.46 -3.37 -9.60
Debt Service Coverage Ratio
 -0.39 -0.59 -0.12 -0.68 -4.18
Interest Coverage Ratio
 -8.57 -1.26 -4.47 -5.70 -7.61
Debt to Market Cap
 0.19 0.22 0.28 0.31 0.14
Interest Debt Per Share
 <0.01 <0.01 <0.01 <0.01 <0.01
Net Debt to EBITDA
 -2.74 -2.32 -22.83 -3.98 -0.34
Profitability Margins
Gross Profit Margin
44.99%45.41%44.60%44.03%46.42%
EBIT Margin
-19.33%-19.19%-16.25%-21.34%-88.92%
EBITDA Margin
-6.37%-5.25%-2.51%-11.08%-77.17%
Operating Profit Margin
-19.33%-3.29%-16.22%-21.34%-36.50%
Pretax Profit Margin
-20.52%-21.80%-19.87%-25.08%-93.71%
Net Profit Margin
-20.91%-21.00%-17.61%-27.68%-96.78%
Continuous Operations Profit Margin
-20.89%-22.30%-20.17%-25.85%-94.96%
Net Income Per EBT
101.88%96.31%88.62%110.36%103.27%
EBT Per EBIT
106.19%662.33%122.50%117.56%256.77%
Return on Assets (ROA)
-26.51%-25.41%-17.84%-27.79%-62.76%
Return on Equity (ROE)
118.31%179.99%61.78%93.69%602.79%
Return on Capital Employed (ROCE)
-366.28%-31.69%-188.81%-131.53%-51.73%
Return on Invested Capital (ROIC)
-94.31%-13.16%-42.66%-56.35%-39.42%
Return on Tangible Assets
-34.66%-33.22%-29.77%-53.53%-94.07%
Earnings Yield
-21.94%-33.09%-14.06%-24.71%-22.38%
Efficiency Ratios
Receivables Turnover
 4.20 6.59 5.28 5.12 6.40
Payables Turnover
 12.95 14.64 6.10 7.64 4.39
Inventory Turnover
 111.80 115.03 149.53 197.86 156.84
Fixed Asset Turnover
 4.14 4.16 2.94 4.33 3.28
Asset Turnover
 1.27 1.21 1.01 1.00 0.65
Working Capital Turnover Ratio
 -2.73 -2.08 -1.64 -3.17 -4.83
Cash Conversion Cycle
 62.04 33.65 11.65 25.40 -23.87
Days of Sales Outstanding
 86.95 55.40 69.09 71.32 57.00
Days of Inventory Outstanding
 3.26 3.17 2.44 1.84 2.33
Days of Payables Outstanding
 28.18 24.92 59.88 47.76 83.20
Operating Cycle
 90.22 58.58 71.53 73.16 59.33
Cash Flow Ratios
Operating Cash Flow Per Share
 <0.01 <0.01 <0.01 >-0.01 >-0.01
Free Cash Flow Per Share
 <0.01 <0.01 <0.01 >-0.01 >-0.01
CapEx Per Share
 <0.01 <0.01 <0.01 <0.01 <0.01
Free Cash Flow to Operating Cash Flow
 0.94 0.97 0.76 1.47 1.71
Dividend Paid and CapEx Coverage Ratio
 17.22 38.82 4.10 -2.11 -1.40
Capital Expenditure Coverage Ratio
 17.22 38.82 4.10 -2.11 -1.40
Operating Cash Flow Coverage Ratio
 0.26 0.46 0.19 -0.10 -0.17
Operating Cash Flow to Sales Ratio
 0.08 0.15 0.11 -0.05 -0.14
Free Cash Flow Yield
7.48%22.81%6.89%-6.32%-5.50%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 -3.33 -3.33 -6.67 -4.05 -4.47
Price-to-Sales (P/S) Ratio
 0.95 0.63 1.25 1.12 4.32
Price-to-Book (P/B) Ratio
 -6.87 -5.44 -4.40 -3.79 -26.93
Price-to-Free Cash Flow (P/FCF) Ratio
 13.38 4.38 14.51 -15.82 -18.20
Price-to-Operating Cash Flow Ratio
 12.60 4.27 10.98 -23.33 -31.16
Price-to-Earnings Growth (PEG) Ratio
 0.02 0.00 0.17 0.07 0.10
Price-to-Fair Value
 -6.87 -5.44 -4.40 -3.79 -26.93
Enterprise Value Multiple
 -17.71 -14.40 -72.81 -14.09 -5.95
Enterprise Value
 14.89M 9.88M 23.15M 20.42M 42.99M
EV to EBITDA
 -17.71 -14.40 -72.81 -14.09 -5.95
EV to Sales
 1.13 0.76 1.83 1.56 4.59
EV to Free Cash Flow
 15.83 5.22 21.14 -22.05 -19.31
EV to Operating Cash Flow
 14.91 5.09 15.99 -32.51 -33.07
Tangible Book Value Per Share
 >-0.01 >-0.01 >-0.01 >-0.01 >-0.01
Shareholders’ Equity Per Share
 >-0.01 >-0.01 >-0.01 >-0.01 >-0.01
Tax and Other Ratios
Effective Tax Rate
 -0.02 -0.02 -0.02 -0.03 -0.01
Revenue Per Share
 <0.01 <0.01 <0.01 <0.01 <0.01
Net Income Per Share
 >-0.01 >-0.01 >-0.01 >-0.01 >-0.01
Tax Burden
 1.02 0.96 0.89 1.10 1.03
Interest Burden
 1.06 1.14 1.22 1.18 1.05
Research & Development to Revenue
 0.00 0.00 0.00 0.00 0.08
SG&A to Revenue
 0.48 0.49 0.54 0.67 0.71
Stock-Based Compensation to Revenue
 0.00 0.00 >-0.01 >-0.01 0.00
Income Quality
 -0.37 -0.68 -0.57 0.19 0.15